OTC Inactive Ingredient Labeling Exemption Requested - Citizen Petition
This article was originally published in The Rose Sheet
Executive Summary
An across-the-board inactive ingredient variance on labeling for OTC drug products with differing ingredients from multiple suppliers is requested in a citizen petition filed with FDA May 16. A slightly revised petition followed on May 23.